Physician profile
Gilbert Schmidt
NPI 1447209994
$2,613.26
in general payments reported to CMS, 2019-2025
7 companies · $40.85 in 2025
The $40.85 reported for 2025 was less than what a typical Addiction Medicine (Internal Medicine) provider received nationally (typical 2025 total: $124).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2021: $19.38 · 2022: $72.35 · 2023: $1,966 · 2024: $397 · 2025: $40.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,898 · Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,897.50 |
| Food and Beverage | $506.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $2,084.25 | 2022-2024 | Sublocade |
| Braeburn INC. | $210.65 | 2024-2025 | Brixadi |
| Gilead Sciences, INC. | $107.33 | 2024 | Epclusa |
| Abbvie INC. | $97.28 | 2019 | |
| Alkermes, INC. | $71.54 | 2021-2025 | Vivitrol |
| Hikma Pharmaceuticals USA | $21.97 | 2022 | |
| Orexo US, INC. | $20.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilbert Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.